Previous close | 130.10 |
Open | 130.18 |
Bid | 127.39 x 400 |
Ask | 127.47 x 100 |
Day's range | 127.04 - 130.23 |
52-week range | 74.75 - 142.00 |
Volume | |
Avg. volume | 3,095,749 |
Market cap | 50.673B |
Beta (5Y monthly) | 1.22 |
PE ratio (TTM) | 82.74 |
EPS (TTM) | 1.54 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 153.37 |
Key Insights The projected fair value for DexCom is US$109 based on 2 Stage Free Cash Flow to Equity With US$130 share...
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Dexcom stock shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.